Greenway Greenhouse Cannabis Corporation (CNSX: GWAY)
Health Care · Pharmaceuticals · CA
CA$0.09
-10.00% today · -55.0% 1Y
Greenway Greenhouse Cannabis Corporation (CNSX: GWAY) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $8.71M and employs 10 people.
Over the last twelve months the share price has lost 55.0%, trading between 0.09 and 0.25.
Tweenvest scores Greenway Greenhouse Cannabis Corporation across four factors: quality 37/100, value 57/100. Its strongest factor is value.
GWAY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.71M
- Revenue (TTM)
- $5.34M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 0.12
- 52-week high
- CA$0.25
- 52-week low
- CA$0.09
- Avg volume (3M)
- —
- Shares outstanding
- 133.25M
- Employees
- 10
- Next earnings
- —
About Greenway Greenhouse Cannabis Corporation
Greenway Greenhouse Cannabis Corporation specializes in the cultivation, processing, and distribution of dried cannabis flower and kief. This company, established in 2018, operates out of Kingsville, Canada, and is a subsidiary of Sunrite Greenhouses Ltd.
- ISIN
- CA39679F2035
- Founded
- 2018
- Listed since
- Sep 22, 2021
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,194.40 | -3.18% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.26 | -1.05% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.24 | -2.05% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.41 | -0.56% |
Figures last refreshed Aug 18, 2026.